GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: example 3 [US20240033264] | GDC-4198 | RGT-419B
Compound class:
Synthetic organic
Comment: The chemical structure for this compound was obtained from WHO INN proposed list 134 (Feb 2026), in which it is described as a cyclin dependent kinase inhibitor with antineoplastic potential. The structure is claimed in patent US20240033264 [1], that was transferred from Regor Pharmaceuticals to Genentech (Roche). Based on this evidence vustanaciclib might be the INN for the lead CDK4/2 inhibitor RGT-419B (new code GDC-4198), that is in development for advanced/metastatic breast cancer that is insensitive to exisiting CDK4/6 inhibitors.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
|||||||||||||||||||||||||||||||||||
Download 2D Structure ![]() |
|
| Canonical SMILES | Download |
| Isomeric SMILES | Download |
| InChI standard identifier | Download |
| InChI standard key | Download |
Molecular structure representations generated using Open Babel